Onyx Healthcare (ROCO:6569) Moat Score: 0/10 (As of Jul. 12, 2026)


ROCO:6569 Onyx Healthcare Inc ROCO:6569
75 GF Score
Price NT$106.50
GF Value NT$121.39
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Onyx Healthcare Moat Score?

Onyx Healthcare has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Onyx Healthcare has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Onyx Healthcare might have No Moat - No discernible moat.

Onyx Healthcare  (ROCO:6569) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Onyx Healthcare Moat Score Related Terms

ROCO:6569
75GF Score
Onyx Healthcare Inc ROCO:6569
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?

Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued. The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39. GuruFocus considers Onyx Healthcare to be Modestly Undervalued.

Key valuation signals for ROCO:6569:

  • Moat Score: 0
  • GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onyx Healthcare Business Description

Address No. 135, Lane 235, Baoqiao Road, 4th Floor, Xindian District, New Taipei, TWN, 231028
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score

Get the complete analysis for ROCO:6569

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$106.50
Price
NT$121.39
GF Value